Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Common Variable Immunodeficiency

Blood & Immune

Common Variable Immunodeficiency (CVID) Clinical Trials

Also called CVID, variable immunodeficiency, hypogammaglobulinemia

Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by low IgG, from severely reduced to just below the normal adult range, with low IgA, IgM or both, combined with impaired specific antibody responses to vaccines and pathogens. The underlying defect involves B cell differentiation and/or inadequate T cell help for B cells, with significant genetic heterogeneity accounting for variable presentations across affected individuals.

In plain words, common variable immunodeficiency is an immune system condition where the body does not make enough antibodies, the proteins that fight germs. People get repeated infections, most often in the sinuses and ears as well as the lungs and gut.

Get an email when new Common Variable Immunodeficiency trials open or the FDA decides. Get alerts

Common Variable Immunodeficiency

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 4 studies with no phase, like observational studies, and 1 phase 4 study following medicines after approval.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Immune globulin

Common Variable Immunodeficiency has 1 FDA-approved medicine, 11 open or active clinical trials (11 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Common Variable Immunodeficiency

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Common Variable Immunodeficiency

Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by low IgG, from severely reduced to just below the normal adult range, with low IgA, IgM or both, combined with impaired specific antibody responses to vaccines and pathogens.

Keep reading about Common Variable Immunodeficiency

The underlying defect involves B cell differentiation and/or inadequate T cell help for B cells, with significant genetic heterogeneity accounting for variable presentations across affected individuals. Pathophysiologically, defects in genes regulating B cell development (TNFRSF13B, PIK3CD, CD19, ICOS, LRBA, and others) impair the ability to generate antibodies effectively.

Recurrent bacterial infections can begin in childhood or adulthood, predominantly affecting sinuses, ears, and respiratory tract (upper and lower). Recurrent gastrointestinal infections with Giardia, other parasites, or bacteria occur frequently. Progressive bronchiectasis develops from recurrent lung infections, significantly impacting pulmonary function and quality of life.

Many patients develop autoimmune manifestations including cytopenias (autoimmune hemolytic anemia, thrombocytopenia), autoimmune gastritis, pernicious anemia, and inflammatory bowel disease with prevalence of 20-30% in CVID populations. Increased rates of malignancies, particularly lymphomas and gastric adenocarcinoma, occur at higher rates than general population. Some patients develop granulomatous complications with granuloma formation in lungs, lymph nodes, or GI tract.

What are the symptoms of Common Variable Immunodeficiency?

These are common symptoms of Common Variable Immunodeficiency, and how strong they are varies from person to person.

  • Recurrent bacterial infections of respiratory tract
  • Recurrent gastrointestinal infections and diarrhea
  • Sinusitis and otitis media
  • Bronchiectasis development
  • Autoimmune manifestations
  • Increased malignancy risk

Who gets Common Variable Immunodeficiency?

Symptoms can begin anytime from childhood to adulthood, and most people are diagnosed in their 20s or 30s, according to MedlinePlus Genetics. It affects males and females equally. Most cases are sporadic, in people with no family history, and a known genetic cause is found in about 10% of cases, according to MedlinePlus Genetics.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Common Variable Immunodeficiency?

There is currently 1 FDA-approved medication for Common Variable Immunodeficiency.

Immune globulin
immune globulin (human)

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Common Variable Immunodeficiency treatment

Charity funds and drugmaker programs for Common Variable Immunodeficiency, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds
  • From a charity · The Assistance Fund
    Primary Immunodeficiency fund
    Waitlist

    Pays for: Copays, coinsurance, deductibles and other health-related expenses.

Status as each foundation showed it on November 17, 2026.

Open the full patient assistance finder →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Common Variable Immunodeficiency

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Common Variable Immunodeficiency resources

Reputable organizations and medical references for learning more about Common Variable Immunodeficiency, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Common Variable Immunodeficiency

Use this Common Variable Immunodeficiency clinical trial finder to see the 11 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 8 test a treatment and 3 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

11 active trials worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenRecently updatedNCT00943514

Natural History of Bronchiectasis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bronchiectasis is a chronic inflammatory and muco-obstructive condition that results in abnormal dilation of the airways, decline in lung function, frequent exacerbations, and chronic respiratory tract infections. Cystic fibrosis (CF) is the most well studied genetic condition th...

Ages 5 Years to 100 Years1 location
Started Aug 2009Updated 6 days agoCompletion date not listed
RecruitingTreatment trialPhase 2Recently updatedNCT04339777

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Intervention: Busulfan test dose, Fludarabine, Busulfan, Alemtuzumab, Total body Irradiation, Allogeneic HSCT, Tacrolimus (Tacro), Mycophenolate mofetil (MMF), Cyclophosphamide (Cytoxan)

Sponsor: National Cancer Institute (NCI)

Background:

During a transplant, blood "stem cells" from one person are given to someone else. The cells grow into the different cells that make up the immune system. This can cure people with certain immunodeficiencies. But transplant has many risks and complications.

Objective:

Ages 4 Years to 69 Years1 location
Started Sep 2020Updated 6 days agoEst. Oct 2028 (~1y 10m)
RecruitingTreatment trialPhase 2Recently updatedNCT02579967

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Intervention: Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditioning-Closed with amendment L, GVHD Prophylaxis, Allo BMT

Sponsor: National Cancer Institute (NCI)

Background:

Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers think this may help people with immune system problems.

Objective:

Ages 4 Years to 75 Years2 locations
Started Nov 2015Updated 1 week agoEst. Dec 2031 (~5y 1m)
RecruitingObservational study, no treatment givenRecently updatedNCT00001244

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

This study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity (IEI). These are conditions where the immune system does not function properly, leading to frequent infections and other complications such as...

Ages 2 Years to 120 Years1 location
Started Jan 1990Updated 2 weeks agoCompletion date not listed
RecruitingTreatment trialPhase 2Recently updatedNCT06976476

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Intervention: IgPro20

Sponsor: Memorial Sloan Kettering Cancer Center

The main purpose of this study is to see if IgPro20 can prevent infection in people with multiple myeloma (MM) who have hypogammaglobulinemia from receiving bispecific monoclonal antibodies (BsAbs).

Ages 18 Years+
Started May 2025Updated 1 month agoEst. May 2029 (~2y 5m)
Find Common Variable Immunodeficiency trials near you, ranked by distance →
Active trial locations18 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+10 more

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 2
Phase 4
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Common Variable Immunodeficiency trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Common Variable Immunodeficiency foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Common Variable Immunodeficiency patient communities

Facebook groups, Reddit communities and YouTube channels where Common Variable Immunodeficiency patients, caregivers and advocacy groups talk.

Companies developing Common Variable Immunodeficiency treatments

Drugmakers that list Common Variable Immunodeficiency in their rare disease portfolio, 3 in all.

Questions people ask about Common Variable Immunodeficiency